
Mario F P Peres
Institution: | São Paulo Headache Center |
City: | São Paulo |
Country: | Brazil |
Biography
Mario F P Peres, MD, PhD, FACP, is the Founder of the São Paulo Headache Center and Program Director of the Headache Medicine training for the Neurology Residency Program at Albert Einstein Hospital in São Paulo, Brazil. Senior Researcher and Professor of Postgraduation at Albert Einstein Hospital and at Psychiatry Institute, São Paulo State University Medical School. Born in São Paulo in 1971, had neurology residency training in 1998, PhD in Neurology in 2000 at Federal University of São Paulo, Headache Fellowship at Jefferson Headache Center, Thomas Jefferson University in 2000-2001.
Dr Peres has authored and/or co-authored more than 130 peer-reviewed publications, book chapters, and a book to headache patients. He has been dedicated the past 15 years full time to the headache field, in clinical practice, academic training, public awareness and research. Developed a headache medicine E-learning program for health professionals, a headache diary app, and internet content with more than 10 million individual page views in the past years.
He has been served as member of several committees at the Internation Headache Society and Brazilian Headache Society, currently part of the Ethics Committee, Cluster Headache Study Group, and Headache Classification working group, and is a member of the IHS-GPAC Core Team.
Disclosures
Employment: Sao Paulo Headache Center; Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
Society Leadership/Board Position: President – ABRACES, Brazilian Headache Association
Professional membership: Brazilian Headache Society; American Headache Society; Brazilian Academy of Neurology
Personal fees: Ache; Abbvie; Eli Lilly; Eurofarma; Libbs; Lundbeck; Novartis; Pfizer; Sanofi; Teva
Research support: CNPq (Conselho Nacional de Desenvolvimento, Científico e Tecnológico, Ministério da Ciência, Tecnologia e Inovação, Governo Brasileiro); FAPESP (Fundação de Amparo ‘a Pesquisa de Sao Paulo); Sociedade Israelita Brasileira Hospital Albert Einstein; Instituto
Vallada; Natura; Janssen-Cilag; Abbvie-Allergan; Eli Lilly; Eurofarma; Libbs; Novartis;
Teva; International Headache Society
Patents: Patent BR 102020020706-7 US 17/196,611
Clinical Trials involvement: CAPTURE study, Abbvie
Relationship with Scientific Journals: Member of the International Classification of Headache Disorders, 3rd Edition; Editor-in-Chief: Headache Medicine (2019-2022); Editorial Board: Journal of Headache and Pain; Arquivos de Neuro-Psiquiatria
Commercial interests: None